Table 3. Subgroup Analysis of Non-ECRSwNP and ECRSwNP Groups.

	Non-ECRSwNP (n=57)		p value	ECRSwNP (n=77)		p value
	Disease-controlled (n=33)	Disease-uncontrolled (n=24)		Disease-controlled (n=46)	Disease-uncontrolled (n=31)
Age (yr)	54 (45–61)	51 (31–59)	0.301*	56 (51–60)	42 (3–54)	0.002*
Sex (male:female)	25:8	17:7	0.911†	38:8	21:10	0.093†
Atopic	18/33 (54.5)	13/23(43.5)	1.000†	22/44 (50)	14/30 (46.7)	0.964†
Asthma	1/33 (3.0)	2/24 (8.3)	0.567‡	5/45 (11.1)	8/31 (25.8)	0.125†
Symptom duration (month)	13.4 (3.3–72.0)	67.7 (24.0–120.0)	0.021*	42 (12–150)	60 (18–120)	0.989*
Lund-Mackay score	14 (11–18)	18 (11–20)	0.274*	14 (10–17)	20 (15–22)	<0.001*
Global osteitis score	9 (6–18)	16 (2–23)	0.096*	11 (4–17)	20 (10–26)	0.008*
BTT	4 (0–8)	3 (0-8)	0.499*	5 (0–8)	0 (0–5)	0.084*
Tissue eosinophil (cells/HPF)	3.3 (0.5–10.6)	10.4 (1.3–29.9)	0.166*	17.3 (6.7–80.0)	70.0 (15.9–105.0)	0.054*
Tissue neutrophil (cells/HPF)	16.5 (9.0–26.8)	46.0 (21.5–69.5)	0.004*	10.3 (3.0–17.7)	15.0 (6.1–40.6)	0.125*
Blood eosinophil (cells/mm3)	116 (79–150)	115 (60–208)	0.897*	308 (239–417)	437 (346–707)	0.002*
Blood neutrophil (cells/mm3)	3623 (3205–4384)	4027 (3022–5251)	0.678*	3702 (2607–4124)	3892 (2779–4879)	0.508*
Current smoking	10/33 (30.3)	7/24 (29.2)	1.000†	13/46 (28.3)	11/31 (35.5)	0.674†
Smoking history (pack-year)	0 (0–18.4)	0 (0–2.5)	0.855*	0 (0–6.0)	0 (0–6.3)	0.587*
Alcohol intake (g/month)	100 (0–672)	28 (0–168)	0.211*	0 (0–224)	0 (0–324.8)	0.928*
Heavy drinker	8/33 (3.4)	3/24 (20)	0.326‡	4/45 (8.9)	2/31 (6.5)	1.000‡
BMI (kg/m2)	24.6 (22.6–26.0)	23.3 (21.4–26.2)	0.268*	24.6 (22.4–26.3)	23.8 (21.9–24.9)	0.262*

ECRSwNP, eosinophilic chronic rhinosinusitis with nasal polyps; BTT, butanol threshold test; HPF, high power field; BMI, body mass index.

Values are presented as medians with IQRs or numbers (percentages).

^*Mann-Whitney U-test, ^†Pearson chi-square test, ^‡Fischer's exact test.